Merrimack Pharmaceuticals (NASDAQ:MACK) Stock Rating Upgraded by StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Merrimack Pharmaceuticals (NASDAQ:MACK) Rating Lowered to Sell at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com downgraded shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Friday morning. Merrimack Pharmaceuticals Stock Performance Shares of MACK opened at $12.19 on Friday. The business has a 50-day moving average of $12.51 and a 200 day moving average […]